Stockreport

Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer [Yahoo! Finance]

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com
PDF Confirmatory Phase 3 trial in first-line (1L) BTC open for enrollment at multiple global sites DUBLIN April 2, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: [Read more]